武汉COVID-19住院患者的神经系统表现
该回顾性观察性病例系列纳入2020年1月16日至2月19日武汉华中科技大学同济医学院附属协和医院3个COVID-19定点诊疗中心连续住院的214例实验室确诊SARS-CoV-2感染患者,由2名培训有素的神经科医生核查全部神经系统症状。结果显示78例(36.4%)存在神经系统表现,且重型感染患者中急性脑血管病、意识障碍和骨骼肌损伤的比例高于非重型患者。
要点
- COVID-19住院患者中神经系统表现常见,总体占36.4%。
- 重型感染患者更易出现急性脑血管病、意识障碍和骨骼肌损伤。
- 疫情期间遇到有神经系统表现的患者,应将SARS-CoV-2感染纳入鉴别诊断。
核心结论
- COVID-19患者常伴神经系统表现,临床应警惕以神经系统症状为首发或突出表现的新冠感染,避免延误诊断或漏诊。
研究设计与样本
- 回顾性、观察性病例系列,数据收集时间为2020年1月16日至2月19日。
- 纳入武汉华中科技大学同济医学院附属协和医院3个COVID-19定点诊疗中心(主院区、西院区、肿瘤中心)连续住院的214例实验室确诊SARS-CoV-2感染患者。
- 临床数据取自电子病历,全部神经系统症状由2名培训有素的神经科医生核查。
主要发现
- 214例患者中位年龄52.7(15.5)岁,男性87例(40.7%);按呼吸状态分为非重型感染126例(58.9%)和重型感染88例(41.1%)。
- 78例(36.4%)出现神经系统表现,分为中枢神经系统、周围神经系统和骨骼肌损伤三类。
- 与重型感染相关的中枢及骨骼肌表现:急性脑血管病5例(5.7%)对1例(0.8%)、意识障碍13例(14.8%)对3例(2.4%)、骨骼肌损伤17例(19.3%)对6例(4.8%)。
- 重型感染患者年龄更大、合并症(尤其高血压)更多,而发热、咳嗽等典型COVID-19症状较少。
临床怎么用
- 接诊有神经系统表现的患者时,在COVID-19流行期间应将SARS-CoV-2感染作为鉴别诊断之一。
- 对重型感染患者应关注急性脑血管病、意识障碍和骨骼肌损伤等神经系统并发症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, is serious and has the potential to become an epidemic worldwide. Several studies have described typical clinical manifestations including fever, cough, diarrhea, and fatigue. However, to our knowledge, it has not been reported that patients with COVID-19 had any neurologic manifestations. OBJECTIVE: To study the neurologic manifestations of patients with COVID-19. DESIGN, SETTING, AND PARTICIPANTS: This is a retrospective, observational case series. Data were collected from January 16, 2020, to February 19, 2020, at 3 designated special care centers for COVID-19 (Main District, West Branch, and Tumor Center) of the Union Hospital of Huazhong University of Science and Technology in Wuhan, China. The study included 214 consecutive hospitalized patients with laboratory-confirmed diagnosis of severe acute respiratory syndrome coronavirus 2 infection. MAIN OUTCOMES AND MEASURES: Clinical data were extracted from electronic medical records, and data of all neurologic symptoms were checked by 2 trained neurologists. Neurologic manifestations fell into 3 categories: central nervous system manifestations (dizziness, headache, impaired consciousness, acute cerebrovascular disease, ataxia, and seizure), peripheral nervous system manifestations (taste impairment, smell impairment, vision impairment, and nerve pain), and skeletal muscular injury manifestations. RESULTS: Of 214 patients (mean [SD] age, 52.7 [15.5] years; 87 men [40.7%]) with COVID-19, 126 patients (58.9%) had nonsevere infection and 88 patients (41.1%) had severe infection according to their respiratory status. Overall, 78 patients (36.4%) had neurologic manifestations. Compared with patients with nonsevere infection, patients with severe infection were older, had more underlying disorders, especially hypertension, and showed fewer typical symptoms of COVID-19, such as fever and cough. Patients with more severe infection had neurologic manifestations, such as acute cerebrovascular diseases (5 [5.7%] vs 1 [0.8%]), impaired consciousness (13 [14.8%] vs 3 [2.4%]), and skeletal muscle injury (17 [19.3%] vs 6 [4.8%]). CONCLUSIONS AND RELEVANCE: Patients with COVID-19 commonly have neurologic manifestations. During the epidemic period of COVID-19, when seeing patients with neurologic manifestations, clinicians should suspect severe acute respiratory syndrome coronavirus 2 infection as a differential diagnosis to avoid delayed diagnosis or misdiagnosis and lose the chance to treat and prevent further transmission.
引用
- Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020. PMID: 32275288. doi:10.1001/jamaneurol.2020.1127
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。